Veracyte, Inc. (VCYT) is a publicly traded Healthcare sector company. As of September 1, 2026, VCYT trades at $43.40 with a market cap of $3.47B and a P/E ratio of 30.03. VCYT moved +0.54% today. Year to date, VCYT is +2.45%; over the trailing twelve months it is +44.24%. Its 52-week range spans $22.61 to $60.91. Analyst consensus is buy with an average price target of $57.75. Rallies surfaces VCYT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for VCYT, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $43.40 |
| Market Cap | $3.47B |
| P/E Ratio | 30.03 |
| EPS | $1.44 |
| Dividend Yield | 0.00% |
| 52-Week High | $60.91 |
| 52-Week Low | $22.61 |
| Volume | 632.08K |
| Avg Volume | 0 |
| Revenue (TTM) | $561.90M |
| Net Income | $114.48M |
| Gross Margin | 71.71% |
9 analysts cover VCYT: 0 strong buy, 7 buy, 1 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $57.75.